Africa Links 24 with Sade Oguntola
Published on 2024-08-22 01:05:02
SYGEN Pharmaceuticals and ORx Pharmaceuticals (Canada) have formed a new joint venture, Sygen-ORX Biosciences, with the intention of addressing local health needs by leveraging on innovation adapted to our environment.
The joint venture development, with academia, the private sector, and the government on board, intends to address local health needs by creating medicines based on pharmacogenetics and genetics that are within the reach of Nigerians while working with local…
Read the Full article on Nigerian Tribune
